David Lough, Ph.D.
Director, Business Development, Life Sciences
(617) 358-4550 • email@example.com
David joined OTD in July 2013, to manage the commercialization of discoveries and ideas in the life sciences, including therapeutics and diagnostics. David has over 16 years of experience growing with start-up and early-stage therapeutics and molecular diagnostics companies, working in a variety of roles including R&D, technology development, customer support, business development, and alliance management.
As Director of Business Development & Alliance Management with Idera Pharmaceuticals, David was an active deal team member for Idera’s out-licensing partnerships in cancer therapeutics and vaccine adjuvants, worth $70 million upfront and $875 million potential total. David started off his career working in a variety of scientific and management positions with the genetic analysis company Sequenom, Inc., including Manager of East Coast Operations. He worked closely with R&D, product development, bioinformatics, marketing, and Sequenom’s clients, to help improve the MassARRAY genotyping platform system and ready it for commercial launch.
David received his Ph.D. in BioOrganic Chemistry and B.Sc. in Environmental Chemistry from the University of Edinburgh, Scotland, and earned a Graduate Certificate in Intellectual Property from Northeastern University, Boston. He is an inventor on seven US patents issued in a variety of technologies related to the analysis of nucleic acids.
Director, Business Development, Physical Sciences
617-358-3795 • firstname.lastname@example.org
Ana joined the Office of Technology Development at Boston University in May 2014. As Director of Business Development, she manages BU’s portfolio of Physical Sciences inventions with the mission to commercialize the university’s technologies, develop stronger university-industry relations as well as support BU’s entrepreneurial activities.
Prior to the OTD, Ana was a founding partner at a consulting company where she connected Brazilian technology based companies with Boston’s innovation ecosystem. Ana also worked as a Business Development Strategist at E Ink where she was responsible for developing strategies for new markets and applications for the company’s leading electronic paper display (EPD) technology. In addition, Ana has many years of experience with technology transfer, having worked at the Technology Licensing Office at the Massachusetts Institute of Technology (MIT). As a Technology Licensing Associate, she assisted with all aspects of technology commercialization from IP evaluation to strategy development and deal negotiations, with a focus on technologies in Clean Energy, Chemistry, Chemical Engineering and Materials.
Ana is a graduate from the University of Toronto where she earned an Honours Bachelor of Science in Astronomy and Physics and is currently pursuing her Master in Business Administration.
Director, Business Development, Medical Technologies
(617) 353-4567 • email@example.com • https://www.linkedin.com/in/leetien
Lee joined the Office of Technology Development in July 2015 as a Director of Business Development. In this role, he manages the commercialization of medical devices, life science tools, diagnostics, and other medical technologies developed by researchers at Boston University and Boston Medical Center.
Prior to joining the OTD, Lee worked in technology transfer at Tufts University where he evaluated, marketed, and commercialized inventions arising from various disciplines including engineering, medicine, and veterinary medicine. Previously, he worked in the financial services industry developing trading and analytics software at an investment bank.
Lee holds a PhD in biomedical engineering from Tufts University, where his research focused on biomaterials, tissue engineering and the nervous system. He also holds a BSE in electrical engineering, with a concentration in computer systems and software, from Princeton University.